Bellevue Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.35K | Hold |
200
| – | – | ﹤0.01% | 391 |
|
|
2025
Q1 | $3.07K | Hold |
200
| – | – | ﹤0.01% | 384 |
|
|
2024
Q4 | $4.41K | Hold |
200
| – | – | ﹤0.01% | 361 |
|
|
2024
Q3 | $3.6K | Hold |
200
| – | – | ﹤0.01% | 351 |
|
|
2024
Q2 | $3.25K | Hold |
200
| – | – | ﹤0.01% | 358 |
|
|
2024
Q1 | $2.82K | Hold |
200
| – | – | ﹤0.01% | 376 |
|
|
2023
Q4 | $2.09K | Hold |
200
| – | – | ﹤0.01% | 402 |
|
|
2023
Q3 | $2.04K | Hold |
200
| – | – | ﹤0.01% | 383 |
|
|
2023
Q2 | $1.51K | Hold |
200
| – | – | ﹤0.01% | 438 |
|
|
2023
Q1 | $1.77K | Hold |
200
| – | – | ﹤0.01% | 426 |
|
|
2022
Q4 | $1.81K | Hold |
200
| – | – | ﹤0.01% | 413 |
|
|
2022
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 433 |
|
|
2022
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 437 |
|
|
2022
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 477 |
|
|
2021
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 518 |
|
|
2021
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 541 |
|
|
2021
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 544 |
|
|
2021
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 601 |
|
|
2020
Q4 | $2K | Sell |
200
-200
| -50% | -$2K | ﹤0.01% | 608 |
|
|
2020
Q3 | $4K | Hold |
400
| – | – | ﹤0.01% | 454 |
|
|
2020
Q2 | $5K | Hold |
400
| – | – | 0.01% | 405 |
|
|
2020
Q1 | $4K | Hold |
400
| – | – | ﹤0.01% | 429 |
|
|
2019
Q4 | $4K | Buy |
+400
| New | +$4K | ﹤0.01% | 372 |
|